Dr. Melissa Carpenter and Carpenter Group Consulting are proven leaders in translating cutting-edge stem cell discoveries into meaningful medical therapies. We simplify complex challenges and provide continuous collaboration to support our clients in achieving results.

We work closely with thought-leading individuals and organizations to:

  • Evaluate new technologies
  • Analyze risks, identify barriers and assess potential
  • Create dynamic preclinical development plans
  • Drive key scientific and funding milestones
  • Facilitate the pathway to clinical outcomes

Our diverse background affords us a full-scale perspective of stem cell therapy development. We combine the flexibility and personal relationship of a strategic consultant with the expertise typically only found in-house at large corporations and research organizations. This unique combination enables us to identify the most critical insights in complex research and more efficiently translate technologies into the next cutting-edge clinical applications.

Carpenter Group Clients Include:
Academic groups
Pharmaceutical companies
Technology firms
Start-ups
Biotech companies
Hospitals
Cell therapy manufacturers
Technology transfer offices
Venture capitalists
Private and industry investors